nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acknowledgement to referees
|
|
|
2018 |
135 |
5 |
p. 805-809 |
artikel |
2 |
BACE1 inhibition more effectively suppresses initiation than progression of β-amyloid pathology
|
Peters, Finn |
|
2018 |
135 |
5 |
p. 695-710 |
artikel |
3 |
Capillary cerebral amyloid angiopathy in Alzheimer’s disease: association with allocortical/hippocampal microinfarcts and cognitive decline
|
Hecht, Moritz |
|
2018 |
135 |
5 |
p. 681-694 |
artikel |
4 |
Correction to: Paragangliomas arise through an autonomous vasculo-angio-neurogenic program inhibited by imatinib
|
Verginelli, Fabio |
|
2018 |
135 |
5 |
p. 799 |
artikel |
5 |
Diffuse gliomas classified by 1p/19q co-deletion, TERT promoter and IDH mutation status are associated with specific genetic risk loci
|
Labreche, Karim |
|
2018 |
135 |
5 |
p. 743-755 |
artikel |
6 |
Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery
|
Jaunmuktane, Zane |
|
2018 |
135 |
5 |
p. 671-679 |
artikel |
7 |
Fatal Aβ cerebral amyloid angiopathy 4 decades after a dural graft at the age of 2 years
|
Hervé, Dominique |
|
2018 |
135 |
5 |
p. 801-803 |
artikel |
8 |
Mechanical disruption of the blood–brain barrier following experimental concussion
|
Johnson, Victoria E. |
|
2018 |
135 |
5 |
p. 711-726 |
artikel |
9 |
NHLRC2 variants identified in patients with fibrosis, neurodegeneration, and cerebral angiomatosis (FINCA): characterisation of a novel cerebropulmonary disease
|
Uusimaa, Johanna |
|
2018 |
135 |
5 |
p. 727-742 |
artikel |
10 |
Paragangliomas arise through an autonomous vasculo-angio-neurogenic program inhibited by imatinib
|
Verginelli, Fabio |
|
2018 |
135 |
5 |
p. 779-798 |
artikel |
11 |
Reconstructing the molecular life history of gliomas
|
Barthel, Floris P. |
|
2018 |
135 |
5 |
p. 649-670 |
artikel |
12 |
Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target
|
Apps, John R. |
|
2018 |
135 |
5 |
p. 757-777 |
artikel |